Antiva Biosciences, Inc
Antiva Biosciences, Inc. is a clinical stage venture-backed biopharmaceutical company developing a novel, first in class, topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions (CIN 2,3).